dextrose monohydrate, sodium chloride - परिणामों की खोज

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

potassium chloride in lactated ringers and dextrose- dextrose monohydrate, sodium chloride, sodium lactate, potassium chloride,

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - potassium chloride in lactated ringer’s and 5% dextrose injection, usp are indicated as a source of water, electrolytes, and calories or as alkalinizing agents. potassium chloride in lactated ringer’s and 5% dextrose injection, usp is contraindicated in:

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

ionosol mb and dextrose- dextrose monohydrate, sodium lactate, potassium chloride, magnesium chloride, potassium phosphate, mono

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), potassium phosphate, monobasic (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosph - dextrose monohydrate 5 g in 100 ml - ionosol mb and 5% dextrose injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution: 15 ml of 5% dextrose and 0.45% sodium chloride injection/kg of body weight. in adults, ionosol mb and 5% dextrose injection is indicated postoperatively for intravenous fluid and electrolyte maintenance therapy, with a small amount of carbohydrate calories for reducing catabolism of endogenous protein reserves. solutions containing potassium are contraindicated in diseases where high potassium levels may be encountered.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sykes 5% dextrose and 0.9% sodium chloride- dextrose monohydrate and sodium chloride injection solution

sypharma pty ltd - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - sykes 5% dextrose and 0.9% sodium chloride injection is indicated as a source of water and calories for all species. sykes 5% dextrose and 0.9% sodium chloride injection is contraindicated in patients with a known allergy to corn or corn products.

इसराइल - अंग्रेज़ी - Ministry of Health

dextrose 4.3 % and 0.18 % sodium chloride vioser solution for infusion

eldan electronic instruments co ltd, israel - dextrose anhydrous; sodium chloride - solution for infusion - dextrose anhydrous 4.3 %w/v; sodium chloride 0.18 %w/v - sodium chloride - dextrose 4.3 % and 0.18 % sodium chloride vioser solution is used in the following indications: dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, over use ofdiuretics) in cases where a source of energy is required (particularly starvation). paediatric population: this product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, high dependency units and intensive care units) for intravenous fluid therapy requiring the use of 0.18% sodium chloride and4% glucose to maintain fluid and electrolyte balance.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

normosol-m and dextrose- dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate injection, solution

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152), magnesium acetate (unii: 0e95jzy48k) (magnesium cation - unii:t6v3lhy838) - dextrose monohydrate 5 g in 100 ml - normosol-m and 5% dextrose injection (multiple electrolytes and 5% dextrose injection type 1, usp) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose. magnesium in the formula may help to prevent iatrogenic magnesium deficiency in patients receiving prolonged parenteral therapy. none known.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

delflex- dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride solution

fresenius medical care north america - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - dextrose monohydrate 1.5 g in 100 ml - delflex® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis. none. risk summary delflex solutions consist of electrolytes, lactate, and bicarbonate at physiological levels, and glucose to facilitate ultrafiltration. while there are no adequate and well controlled studies in pregnant women, appropriate administration of delflex with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm. animal reproduction studies have not been conducted with delflex. the estimated background risk of major birth defects and miscarriage for the indicated population are unknown. all pregnancies have a background risk of birth defect, loss or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary the components of delflex solutions are excreted in human milk. appropriat

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

delflex neutral ph- dextrose monohydrate, sodium chloride, calcium chloride, magnesium chloride, sodium lactate solution

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

dextrose and sodium chloride injection solution

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 5 g in 100 ml

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sodium chloride injection, solution

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 1 ml - sodium chloride injection, usp is indicated for parenteral restoration of sodium ion in patients with restricted oral intake. sodium replacement is specifically indicated in patients with hyponatremia or low salt syndrome. sodium chloride injection may also be added to compatible carbohydrate solutions such as dextrose in water to provide electrolytes. sodium chloride injection is contraindicated in patients with hypernatremia or fluid retention.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

sodium chloride injection

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 1 ml - sodium chloride injection, usp, 23.4%, is indicated as an additive in parenteral fluid therapy for use in patients who have special problems of sodium electrolyte intake or excretion. it is intended to meet the specific requirements of the patient with unusual fluid and electrolyte needs. after available clinical and laboratory information is considered and correlated, the appropriate number of milliequivalents of sodium chloride required can be withdrawn from sodium chloride injection, usp, 23.4% and diluted for use. sodium chloride injection is indicated for the treatment of sodium, chloride and water deficiencies that commonly occur in many diseases. isotonic sodium chloride injection should be limited to cases in which the chloride loss is greater than the sodium loss, as in vomiting from pyloric obstruction, or in which the loss is about equal, as in vomiting from duodenal, jejunal or ileal obstruction and in the replacement of aspirated gastrointestinal fluids. the toxic symptoms that follow various